|
|
||||||||
1 Department of Microbiology and Immunology, Tohoku University Graduate School of Dentistry, Sendai, Japan
2 Division of Microbiology and Oral Infection, Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
3 Division of Molecular Pathology, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
4 Department of Microbiology, Faculty of Biotechnology, Jagiellonian University, Kraków, Poland
5 Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, USA
Correspondence
Akiko Uehara
kyoro{at}mail.tains.tohoku.ac.jp
Received 8 October 2007
Accepted 19 December 2007
B), the Kgp- and HRgpA-mediated downregulation was not negated in NF-
B-silenced cells. Both the haemagglutinin and the enzymic domains are required for Kgp and HRgpA to downregulate the production of IL-8 in human oral epithelial cells, and the two domains are thought to co-exist. These results suggest that gingipains preferentially suppress IL-8, resulting in attenuation of the cellular recognition of bacteria, and as a consequence, sustain chronic inflammation.
Abbreviations: FPR-cmk, Phe-Pro-Arg-chloromethyl ketone; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HRgpA, high-molecular-mass arginine-specific gingipain; IFN-
, gamma interferon; IL, interleukin; Kgp, lysine-specific gingipain; NF-
B, nuclear factor-kappa B; PAR, protease-activated receptor; Rgp, arginine-specific gingipain; PAR-1AP, PAR-1 agonist peptide; PAR-2AP, PAR-2 agonist peptide; PAR-3AP, PAR-3 agonist peptide; siRNA, short interfering RNA; z-FKck, benzyloxycarbonyl-Phe-Lys-chloromethyl; TNF-
, tumour necrosis factor alpha.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |